Brind.

The FDA cleared a diagnostic test, with the involved companies being Adaptive Biotechnologies and Fortrea Holdings Inc.

1 report, 0 independent Updated Jun 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

FDA Adaptive Biotechnologies

Keep exploring

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
Adaptive Biotechnologies
company in Seattle, United States
- Adaptive Biotechnologies presented findings at the IMS meeting in Glasgow on September 25, 2026.Fri 14:06

Related events

Trinity Biotech announced that its Premier Hb9210™ analyser received FDA clearance and the company plans to accelerate growth across its diagnostics franchise in Europe.Aug 28
FDA clearance drives market expansion and coverage for NeurAxis, Inc.Jun 7
GSK is submitting data to the FDA regarding potential expansion of its drug indications.Sep 14

Coverage

Newest first; wire copies grouped

Jun 26Unknown outlet